Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis.

Abstract

The interactions of CD28-B7 and CD40-CD40 ligand (CD40L) pathways in T cell costimulation and autoimmune disease are incompletely understood. We sought to address this issue by investigation of the genesis of acetylcholine receptor (AChR)-induced antibody-mediated experimental autoimmune myasthenia gravis (EAMG) in CD28- and CD40L-deficient mice (CD28-/-, CD40L-/-). Compared to wild-type mice, the CD28-/- mice became less susceptible, and CD40L-/- mice were completely resistant to EAMG induction. Analysis of T helper functions, reflected by cytokine responses, revealed a switch to a Th1 profile in CD28-/- mice. Consistently, levels of serum AChR-specific antibodies of the IgG1 isotype were decreased in CD28-/- mice. In the CD40L-/- mice, both Th1 and Th2 cytokine responses were diminished, and T cell-dependent AChR-reactive B cell responses were more severely impaired than in the CD28-/- mice. Thus, CD28 and CD40L are differentially required for induction of EAMG.

Statistics

050'99'01'03'05'07'09'11'13'15'17
Citations per Year

127 Citations

Semantic Scholar estimates that this publication has 127 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Shi1998DifferentialRF, title={Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis.}, author={F D Shi and B L He and H Li and Darius Matusevicius and Hans Link and H G Ljunggren}, journal={European journal of immunology}, year={1998}, volume={28 11}, pages={3587-93} }